Histotripsy is a new, FDA-approved, minimally invasive technique that destroys liver tumors using high-frequency ultrasound ...

A newly published review in eGastroenterology compiles recent research on alcohol-associated liver disease (ALD), offering an overview of its pathogenesis and efforts to better understand this ...

Bluejay Therapeutics, Inc., a clinical-stage biopharmaceutical company rapidly progressing transformative therapies for viral ...

The Barbara Ann Karmanos Cancer Institute, a part of McLaren Health Care, has commenced the prescription of a new ...

A new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann ...

RedePHine phase 1/2 clinical trial initiation expected in first half of 2025CAMBRIDGE, Mass., Dec. 19, 2024 (GLOBE NEWSWIRE) ...

Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...

It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...

The FDA has placed its most serious warning - called a Boxed Warning - on the non-hormonal drug fezolinetant, which is sold ...

Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...